113 related articles for article (PubMed ID: 37919054)
1. The Effect of Liraglutide on Lung Cancer and Its Potential Protective Effect on High Glucose-Induced Lung Senescence and Oxidative Damage.
Pu Z; Yang Y; Qin S; Li X; Cui C; Chen W
Front Biosci (Landmark Ed); 2023 Oct; 28(10):259. PubMed ID: 37919054
[TBL] [Abstract][Full Text] [Related]
2. Activation of glucagon-like peptide-1 receptor inhibits tumourigenicity and metastasis of human pancreatic cancer cells via PI3K/Akt pathway.
Zhao H; Wang L; Wei R; Xiu D; Tao M; Ke J; Liu Y; Yang J; Hong T
Diabetes Obes Metab; 2014 Sep; 16(9):850-60. PubMed ID: 24641303
[TBL] [Abstract][Full Text] [Related]
3. Liraglutide attenuates high glucose-induced abnormal cell migration, proliferation, and apoptosis of vascular smooth muscle cells by activating the GLP-1 receptor, and inhibiting ERK1/2 and PI3K/Akt signaling pathways.
Shi L; Ji Y; Jiang X; Zhou L; Xu Y; Li Y; Jiang W; Meng P; Liu X
Cardiovasc Diabetol; 2015 Feb; 14():18. PubMed ID: 25855361
[TBL] [Abstract][Full Text] [Related]
4. [Protective effect of glucagon-like peptide-1 analogue on cardiomyocytes injury induced by hypoxia/reoxygenation].
Liu MM; Shen YF; Chen C; Lai XY; Zhang MY; Yu R
Zhonghua Nei Ke Za Zhi; 2016 Apr; 55(4):311-6. PubMed ID: 27030622
[TBL] [Abstract][Full Text] [Related]
5. Liraglutide inhibits the apoptosis of human nucleus pulposus cells induced by high glucose through PI3K/Akt/caspase-3 signaling pathway.
Ming-Yan Y; Jing Z; Shu-Qin G; Xiao-Liang B; Zhi-Hong L; Xue Z
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31383790
[TBL] [Abstract][Full Text] [Related]
6. Liraglutide Attenuates Myocardial Ischemia/Reperfusion Injury Through the Inhibition of Necroptosis by Activating GLP-1R/PI3K/Akt Pathway.
Zhou G; Wu H; Yang J; Ye M; Liu D; Li Y; Zhang D; Zhang J; Yang Q; Liu Y
Cardiovasc Toxicol; 2023 Apr; 23(3-4):161-175. PubMed ID: 36934206
[TBL] [Abstract][Full Text] [Related]
7. Protective action of liraglutide in beta cells under lipotoxic stress via PI3K/Akt/FoxO1 pathway.
Shao S; Nie M; Chen C; Chen X; Zhang M; Yuan G; Yu X; Yang Y
J Cell Biochem; 2014 Jun; 115(6):1166-75. PubMed ID: 24415347
[TBL] [Abstract][Full Text] [Related]
8. Root extract of Hemsleya amabilis Diels suppresses renal cell carcinoma cell growth through inducing apoptosis and G
Li K; You G; Jiang K; Wang R; Li W; Meng Y; Fang Y; Chen W; Zhu G; Song J; Wang W; Su H; Hu B; Sun F; Jia Z; Li C; Zhu J
J Ethnopharmacol; 2024 Jan; 318(Pt B):117014. PubMed ID: 37557938
[TBL] [Abstract][Full Text] [Related]
9. Proanthocyanidins inhibit the apoptosis and aging of nucleus pulposus cells through the PI3K/Akt pathway delaying intervertebral disc degeneration.
Chen HW; Liu MQ; Zhang GZ; Zhang CY; Wang ZH; Lin AX; Kang JH; Liu WZ; Guo XD; Wang YD; Kang XW
Connect Tissue Res; 2022 Nov; 63(6):650-662. PubMed ID: 35491814
[TBL] [Abstract][Full Text] [Related]
10. Glucagon-like Peptide-1 Analogues Inhibit Proliferation and Increase Apoptosis of Human Prostate Cancer Cells in vitro.
Li XN; Bu HM; Ma XH; Lu S; Zhao S; Cui YL; Sun J
Exp Clin Endocrinol Diabetes; 2017 Feb; 125(2):91-97. PubMed ID: 28008585
[No Abstract] [Full Text] [Related]
11. Liraglutide prevents beta-amyloid-induced neurotoxicity in SH-SY5Y cells via a PI3K-dependent signaling pathway.
Liu XY; Wang LX; Chen Z; Liu LB
Neurol Res; 2016 Apr; 38(4):313-9. PubMed ID: 27108910
[TBL] [Abstract][Full Text] [Related]
12. Liraglutide Attenuates Restenosis After Vascular Injury in Rabbits With Diabetes Via the TGF-β/Smad3 Signaling Pathway.
Ding HX; Dong NX; Zhou CX; Wang FJ; Xing N; Ma HF; Hou L
Altern Ther Health Med; 2022 Sep; 28(6):22-28. PubMed ID: 35751893
[TBL] [Abstract][Full Text] [Related]
13. The neuroprotection of liraglutide on diabetic cognitive deficits is associated with improved hippocampal synapses and inhibited neuronal apoptosis.
Yan W; Pang M; Yu Y; Gou X; Si P; Zhawatibai A; Zhang Y; Zhang M; Guo T; Yi X; Chen L
Life Sci; 2019 Aug; 231():116566. PubMed ID: 31201846
[TBL] [Abstract][Full Text] [Related]
14. Synergistic anti-tumor effects of Liraglutide, a glucagon-like peptide-1 receptor agonist, along with Docetaxel on LNCaP prostate cancer cell line.
Eftekhari S; Montazeri H; Tarighi P
Eur J Pharmacol; 2020 Jul; 878():173102. PubMed ID: 32283060
[TBL] [Abstract][Full Text] [Related]
15. GLP-1 receptor agonist liraglutide inhibits the proliferation and migration of thyroid cancer cells.
Zhang X; Zhang L; Wang B; Zhang X; Gu L; Guo K; Zhang X; Zhou Z
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):221-225. PubMed ID: 38279433
[TBL] [Abstract][Full Text] [Related]
16. [Decursin affects proliferation, apoptosis, and migration of colorectal cancer cells through PI3K/Akt signaling pathway].
Yang Y; Hu YE; Zhao MY; Jiang YF; Fu X; You FM
Zhongguo Zhong Yao Za Zhi; 2023 May; 48(9):2334-2342. PubMed ID: 37282862
[TBL] [Abstract][Full Text] [Related]
17. Liraglutide, a glucagon-like peptide-1 receptor agonist, facilitates osteogenic proliferation and differentiation in MC3T3-E1 cells through phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT), extracellular signal-related kinase (ERK)1/2, and cAMP/protein kinase A (PKA) signaling pathways involving β-catenin.
Wu X; Li S; Xue P; Li Y
Exp Cell Res; 2017 Nov; 360(2):281-291. PubMed ID: 28919123
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1 analogue liraglutide facilitates wound healing by activating PI3K/Akt pathway in keratinocytes.
Nagae K; Uchi H; Morino-Koga S; Tanaka Y; Oda M; Furue M
Diabetes Res Clin Pract; 2018 Dec; 146():155-161. PubMed ID: 30367901
[TBL] [Abstract][Full Text] [Related]
19. [Mitochondrial coenzyme Q attenuates lipopolysaccharide-induced mitochondria-dependent apoptosis in type II alveolar epithelial cells via phosphatidylinositol 3-kinase/Akt pathway].
Zhou J; Gao J; Fang Q
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Apr; 34(4):378-382. PubMed ID: 35692202
[TBL] [Abstract][Full Text] [Related]
20. [Tanshinone ⅡA activates PI3K/AKT signaling pathway to inhibit the apoptosis of mice cochlear pericytes induced by high glucose].
Shi TF; Jia JJ; Huang TL; Ma JW; Si JQ; Ma KT; Li L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Jul; 58(7):681-689. PubMed ID: 37455113
[No Abstract] [Full Text] [Related]
[Next] [New Search]